Skip to content

HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents

Effects of a Multidisciplinary Team-led School-based Human Papillomavirus Vaccination Health-promotion Programme (MDL-SHPVP) on Improving Vaccine Acceptance and Uptake Among Female Adolescents: A Cluster Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04438291
Enrollment
1340
Registered
2020-06-18
Start date
2020-12-01
Completion date
2024-05-28
Last updated
2024-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Attitude, Health Behavior, HPV Infection

Brief summary

The MDL-SHPVP will be developed and a clustered randomised controlled trial will be conducted to evaluate the effects of the MDL-SHPVP and to examine whether the effect of the MDL-SHPVP on the rate of HPV vaccine uptake 1 year after intervention is mediated by parents'/guardians' and female adolescents' HPV knowledge, attitudes and beliefs, adolescents' intention to receive HPV vaccination and vaccine acceptance among their parents/guardians.

Detailed description

2520 adolescents and their parents or guardians from 18 local secondary day schools will be recruited. Multicomponent interventions will be offered to the intervention schools. To build and strengthen the community capacity in health promotion, a team of volunteers will be established to raise awareness of HPV, cervical cancer and HPV vaccine. Data will be collected at baseline, 1 month and 1 year after intervention. The mixed-effects model will be used to compare the differential changes for each of the primary and secondary outcomes across time between the two groups. The project is expected to instil a more accurate understanding of HPV and HPV vaccination and support the decision to undergo vaccination.

Interventions

OTHERMDL-SHPVP

A 2-hour education session with multicomponent interventions including education sessions with small group dialogues with a registered nurse and trained healthcare and lay volunteers and educational computer games

OTHER30-minute educational video

A 30-minute education video (DVD) on HPV, cervical cancer and the HPV vaccine that is designed to enhance HPV vaccine acceptance

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Female; * Age 14-17 years;

Exclusion criteria

* Have received the HPV vaccination before

Design outcomes

Primary

MeasureTime frameDescription
Female adolescents' uptake of the HPV vaccine1 year post-interventionSelf report uptake of the HPV vaccine by the female adolescents in the past 12 months.

Secondary

MeasureTime frameDescription
Change of female adolescents' intention to receive HPV vaccinationbaseline, 1 month post-interventionA 10-point Likert scale will be used to measure the intention indicates Definitely. 1 indicates Definitely not and 10 indicates Definitely. Higher value means higher intention.
Change of vaccine acceptance among parents/guardiansbaseline, 1 month post-interventionPrecaution Adoption Process Model will be used to measure the vaccine acceptance.
Change of female adolescents' and parents'/ guardians' HPV knowledgebaseline, 1 month post-interventionHPV General and HPV Vaccine Knowledge Scale will be used to measure the knowledge.1 point will be given to each correct answer and 0 points will be given to each incorrect or Don't know answer. Higher scores mean more HPV knowledge.
Change of female adolescents' HPV attitudes and beliefsbaseline, 1 month post-interventionCarolina HPV Immunisation Attitudes and Beliefs Scale will be used to measure the attitudes and belief. An 11-point Likert scale will be used, with 0, 5, 7 and 10 indicate strongly disagree, somewhat disagree, somewhat agree and strongly agree respectively, or indicate extremely ineffective, somewhat ineffective, somewhat effective and extremely effective respectively. Higher values mean stronger agreement with the statement and less agreement with or endorsement of HPV vaccination. Five items will be reverse-coded.
Change of parents'/ guardians' HPV attitudes and beliefsbaseline, 1 month post-interventionCarolina HPV Immunisation Attitudes and Beliefs Scale will be used to measure the attitudes and belief. A 4-point Likert scale will be used. 1,2,3 and 4 indicate strongly disagree, somewhat disagree, somewhat agree, and strongly agree respectively. Higher values indicate stronger agreement with the statement.

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026